Approvals/TGA/VELMETIA 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg tablet blister pack

Approved

STANDARD

VELMETIA 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6bc6e07c323e14bc
Product Name: VELMETIA 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg tablet blister pack
Artg Id: 220155
Artg Name: VELMETIA 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg tablet blister pack
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2014-11-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/eda60fd0827c4e42d5fbd19b61cff201.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f9cfabeea2062702a2116906a165ef56.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

6bc6e07c323e14bc

Type

Standard